👉🏻 ATNF (180 Life Sciences) Under the radar gem is an understatement. Potentially and very likely will soar 25X or more current stock price . Co-Founded by Prof. Raphael Mechoulam "THE GODFATHER Of Cannabis Research" Discovered the Endocannabinoid system and isolating the two primary compounds, CBD and THC. ATNF has a Tiny 1 million share Float (Most likely much smaller at this point) with an addressable $150 Billion in revenues worldwide pipelines to address unmet needs of the number #1 cause of all autoimmune diseases in the world (Inflammation) and Chronic Pain Therapies with the Best Minds in the world. Dream Team All Star Management created drugs and companies that sold for close to $100 BILLION. They are in phase 3 the last phase which has an incredibly high (estimate greater then 90% ) likelihood of FDA approval of a potential $7.5 Billion (UK and US) and probably 20+ Billion worldwide therapy for Dupuytren’s Disease which there is no other treatment available. Phase 2 exceeded all primary endpoints. They are fully funded with grants (only the best of the best 1% ers receives grants) and cash on hand for 3 years as per CEO 3 weeks ago on latest presentation. Market cap is tiny around $60 million. Management owns 50% of the outstanding shares and 72% of outstanding shares cannot be sold for 12 Months.180 Life Sciences is an applicant and licensee of a broad and growing patent portfolio for three major drug platforms in the areas of inflammation, fibrosis and pain. The patent portfolio covers 16 patent families with 42 patents issued and 32 pending in several important jurisdictions, including the US, Canada, Europe, Australia, Japan and China. Portfolio alone is worth 8X the current stock price.
heat!
GW for tomorrow morning It’s good to go or should we wait
Let’s go, love your videos man!
nice..
0:24
lon.in.net
👉🏻 ATNF (180 Life Sciences) Under the radar gem is an understatement. Potentially and very likely will soar 25X or more current stock price . Co-Founded by Prof. Raphael Mechoulam "THE GODFATHER Of Cannabis Research" Discovered the Endocannabinoid system and isolating the two primary compounds, CBD and THC. ATNF has a Tiny 1 million share Float (Most likely much smaller at this point) with an addressable $150 Billion in revenues worldwide pipelines to address unmet needs of the number #1 cause of all autoimmune diseases in the world (Inflammation) and Chronic Pain Therapies with the Best Minds in the world. Dream Team All Star Management created drugs and companies that sold for close to $100 BILLION. They are in phase 3 the last phase which has an incredibly high (estimate greater then 90% ) likelihood of FDA approval of a potential $7.5 Billion (UK and US) and probably 20+ Billion worldwide therapy for Dupuytren’s Disease which there is no other treatment available. Phase 2 exceeded all primary endpoints. They are fully funded with grants (only the best of the best 1% ers receives grants) and cash on hand for 3 years as per CEO 3 weeks ago on latest presentation. Market cap is tiny around $60 million. Management owns 50% of the outstanding shares and 72% of outstanding shares cannot be sold for 12 Months.180 Life Sciences is an applicant and licensee of a broad and growing patent portfolio for three major drug platforms in the areas of inflammation, fibrosis and pain. The patent portfolio covers 16 patent families with 42 patents issued and 32 pending in several important jurisdictions, including the US, Canada, Europe, Australia, Japan and China. Portfolio alone is worth 8X the current stock price.
hopefully this is soon!!!
loaded up on $sndl fasho
Let’s go!!!!